nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—MPO—Propylthiouracil—Graves' disease	0.898	1	CbGbCtD
Tolmetin—Lymphadenopathy—Methimazole—Graves' disease	0.00525	0.092	CcSEcCtD
Tolmetin—Zolpidem—GABRA3—Graves' disease	0.00497	1	CrCbGaD
Tolmetin—Lymphadenopathy—Propylthiouracil—Graves' disease	0.00446	0.0782	CcSEcCtD
Tolmetin—Drowsiness—Methimazole—Graves' disease	0.00345	0.0605	CcSEcCtD
Tolmetin—Agranulocytosis—Methimazole—Graves' disease	0.00322	0.0564	CcSEcCtD
Tolmetin—Hepatitis—Methimazole—Graves' disease	0.0031	0.0543	CcSEcCtD
Tolmetin—Drowsiness—Propylthiouracil—Graves' disease	0.00294	0.0514	CcSEcCtD
Tolmetin—Agranulocytosis—Propylthiouracil—Graves' disease	0.00274	0.048	CcSEcCtD
Tolmetin—Hepatitis—Propylthiouracil—Graves' disease	0.00263	0.0462	CcSEcCtD
Tolmetin—Oedema—Methimazole—Graves' disease	0.0022	0.0386	CcSEcCtD
Tolmetin—Thrombocytopenia—Methimazole—Graves' disease	0.00216	0.0378	CcSEcCtD
Tolmetin—Somnolence—Methimazole—Graves' disease	0.00196	0.0343	CcSEcCtD
Tolmetin—Dyspepsia—Methimazole—Graves' disease	0.00194	0.034	CcSEcCtD
Tolmetin—Oedema—Propylthiouracil—Graves' disease	0.00187	0.0328	CcSEcCtD
Tolmetin—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00183	0.0321	CcSEcCtD
Tolmetin—Urticaria—Methimazole—Graves' disease	0.00175	0.0306	CcSEcCtD
Tolmetin—Body temperature increased—Methimazole—Graves' disease	0.00174	0.0305	CcSEcCtD
Tolmetin—Somnolence—Propylthiouracil—Graves' disease	0.00166	0.0292	CcSEcCtD
Tolmetin—Dyspepsia—Propylthiouracil—Graves' disease	0.00165	0.0289	CcSEcCtD
Tolmetin—Urticaria—Propylthiouracil—Graves' disease	0.00149	0.0261	CcSEcCtD
Tolmetin—Body temperature increased—Propylthiouracil—Graves' disease	0.00148	0.0259	CcSEcCtD
Tolmetin—Vomiting—Methimazole—Graves' disease	0.0014	0.0245	CcSEcCtD
Tolmetin—Headache—Methimazole—Graves' disease	0.00138	0.0242	CcSEcCtD
Tolmetin—TDO2—Monoamine Transport—IL1B—Graves' disease	0.00135	0.0374	CbGpPWpGaD
Tolmetin—Nausea—Methimazole—Graves' disease	0.00131	0.0229	CcSEcCtD
Tolmetin—Vomiting—Propylthiouracil—Graves' disease	0.00119	0.0209	CcSEcCtD
Tolmetin—Headache—Propylthiouracil—Graves' disease	0.00117	0.0205	CcSEcCtD
Tolmetin—Nausea—Propylthiouracil—Graves' disease	0.00111	0.0195	CcSEcCtD
Tolmetin—TDO2—pituitary gland—Graves' disease	0.00103	0.253	CbGeAlD
Tolmetin—TDO2—Monoamine Transport—TNF—Graves' disease	0.000982	0.0272	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Graves' disease	0.000904	0.025	CbGpPWpGaD
Tolmetin—CXCL8—Chemokine receptors bind chemokines—CXCL10—Graves' disease	0.000749	0.0207	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.000721	0.02	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—IFNG—Graves' disease	0.000709	0.0196	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—CD4—Graves' disease	0.000685	0.019	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—IL2RA—Graves' disease	0.000658	0.0182	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Graves' disease	0.000654	0.0181	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—HLA-E—Graves' disease	0.000651	0.018	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—CD40—Graves' disease	0.000636	0.0176	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—IL1B—Graves' disease	0.000633	0.0175	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—CTLA4—Graves' disease	0.000627	0.0174	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Graves' disease	0.000627	0.0173	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—ICAM1—Graves' disease	0.000587	0.0162	CbGpPWpGaD
Tolmetin—CXCL8—Overview of nanoparticle effects—TNF—Graves' disease	0.00058	0.0161	CbGpPWpGaD
Tolmetin—CXCL8—pituitary gland—Graves' disease	0.000567	0.139	CbGeAlD
Tolmetin—CXCL8—adipose tissue—Graves' disease	0.000565	0.139	CbGeAlD
Tolmetin—MPO—Vitamin B12 Metabolism—IFNG—Graves' disease	0.000549	0.0152	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	0.000519	0.0144	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—HLA-DQB1—Graves' disease	0.000516	0.0143	CbGpPWpGaD
Tolmetin—CXCL8—EBV LMP1 signaling—TNF—Graves' disease	0.000498	0.0138	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—IL1B—Graves' disease	0.000489	0.0135	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—HLA-A—Graves' disease	0.000473	0.0131	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000466	0.0129	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—HLA-B—Graves' disease	0.000464	0.0128	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	0.000464	0.0128	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—TNF—Graves' disease	0.000459	0.0127	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—FASLG—Graves' disease	0.000453	0.0125	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—IFNG—Graves' disease	0.000446	0.0124	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—Graves' disease	0.000443	0.0123	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—FAS—Graves' disease	0.000437	0.0121	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IL2RA—Graves' disease	0.000435	0.012	CbGpPWpGaD
Tolmetin—MPO—connective tissue—Graves' disease	0.00043	0.106	CbGeAlD
Tolmetin—CXCL8—Allograft Rejection—HLA-A—Graves' disease	0.00043	0.0119	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Graves' disease	0.000424	0.0117	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000413	0.0114	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CXCL10—Graves' disease	0.000413	0.0114	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	0.000405	0.0112	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—IL1B—Graves' disease	0.000398	0.011	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Graves' disease	0.000396	0.011	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—HLA-DRB1—Graves' disease	0.000393	0.0109	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—ICAM1—Graves' disease	0.000366	0.0101	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—IFNG—Graves' disease	0.000362	0.01	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	0.000362	0.01	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—CD4—Graves' disease	0.000356	0.00984	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—TNF—Graves' disease	0.000355	0.00983	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IFNG—Graves' disease	0.000355	0.00981	CbGpPWpGaD
Tolmetin—MPO—pituitary gland—Graves' disease	0.000331	0.0814	CbGeAlD
Tolmetin—TDO2—Metabolism—GC—Graves' disease	0.00033	0.00914	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—TNF—Graves' disease	0.00032	0.00886	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IL1B—Graves' disease	0.000316	0.00875	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IFNG—Graves' disease	0.000316	0.00874	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000293	0.0081	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—TNF—Graves' disease	0.000289	0.008	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IFNG—Graves' disease	0.000287	0.00794	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Graves' disease	0.000286	0.00792	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CXCL10—Graves' disease	0.000282	0.0078	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Graves' disease	0.00028	0.00775	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IFNG—Graves' disease	0.000278	0.0077	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Graves' disease	0.000275	0.0076	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—ICAM1—Graves' disease	0.000273	0.00757	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000268	0.00741	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IL1B—Graves' disease	0.000256	0.00708	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—TNF—Graves' disease	0.000254	0.00703	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—B3GNT2—Graves' disease	0.00025	0.00692	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—CXCL10—Graves' disease	0.000238	0.00658	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—TNF—Graves' disease	0.00023	0.00635	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IFNG—Graves' disease	0.000228	0.00632	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—TSHR—Graves' disease	0.000223	0.00616	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL1B—Graves' disease	0.000208	0.00577	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IFNG—Graves' disease	0.000208	0.00576	CbGpPWpGaD
Tolmetin—PTGS1—connective tissue—Graves' disease	0.000204	0.0501	CbGeAlD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL1B—Graves' disease	0.000204	0.00564	CbGpPWpGaD
Tolmetin—PTGS2—connective tissue—Graves' disease	0.000195	0.0479	CbGeAlD
Tolmetin—PTGS1—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000191	0.00528	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—B3GNT2—Graves' disease	0.000189	0.00523	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000189	0.00523	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—TNF—Graves' disease	0.000186	0.00514	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL1B—Graves' disease	0.000186	0.00513	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000181	0.00501	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CXCL10—Graves' disease	0.000181	0.005	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000174	0.00482	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.000163	0.0045	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000159	0.00441	CbGpPWpGaD
Tolmetin—PTGS1—pituitary gland—Graves' disease	0.000157	0.0386	CbGeAlD
Tolmetin—PTGS1—adipose tissue—Graves' disease	0.000157	0.0385	CbGeAlD
Tolmetin—PTGS2—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000151	0.00419	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000151	0.00419	CbGpPWpGaD
Tolmetin—PTGS2—pituitary gland—Graves' disease	0.00015	0.0369	CbGeAlD
Tolmetin—PTGS2—adipose tissue—Graves' disease	0.00015	0.0368	CbGeAlD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000148	0.00411	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IFNG—Graves' disease	0.000145	0.00402	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CXCL10—Graves' disease	0.000144	0.00398	CbGpPWpGaD
Tolmetin—PTGS1—thyroid gland—Graves' disease	0.000136	0.0333	CbGeAlD
Tolmetin—CXCL8—Spinal Cord Injury—TNF—Graves' disease	0.000135	0.00373	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL1B—Graves' disease	0.000129	0.00358	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000126	0.0035	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—TSHR—Graves' disease	0.000126	0.00348	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	0.000125	0.00347	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—ICAM1—Graves' disease	0.00012	0.00331	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	0.000118	0.00327	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000117	0.00324	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CD4—Graves' disease	0.000115	0.0032	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IFNG—Graves' disease	0.000115	0.00319	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—TSHR—Graves' disease	0.000114	0.00316	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000108	0.00298	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL1B—Graves' disease	0.000103	0.00284	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	9.8e-05	0.00271	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	9.45e-05	0.00262	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—TNF—Graves' disease	9.39e-05	0.0026	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IFNG—Graves' disease	9.11e-05	0.00252	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CXCL10—Graves' disease	8.13e-05	0.00225	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL1B—Graves' disease	8.13e-05	0.00225	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—Graves' disease	7.46e-05	0.00206	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CXCL10—Graves' disease	7.39e-05	0.00204	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GC—Graves' disease	7.1e-05	0.00196	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TSHR—Graves' disease	6.75e-05	0.00187	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2RA—Graves' disease	6.22e-05	0.00172	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—Graves' disease	5.9e-05	0.00163	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2RA—Graves' disease	5.65e-05	0.00156	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GC—Graves' disease	5.63e-05	0.00156	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—B3GNT2—Graves' disease	5.38e-05	0.00149	CbGpPWpGaD
Tolmetin—PTGS2—Disease—B3GNT2—Graves' disease	5.1e-05	0.00141	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CXCL10—Graves' disease	4.36e-05	0.00121	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—B3GNT2—Graves' disease	4.27e-05	0.00118	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	4.01e-05	0.00111	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2RA—Graves' disease	3.34e-05	0.000923	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HLA-A—Graves' disease	2.06e-05	0.000571	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD4—Graves' disease	1.33e-05	0.000368	CbGpPWpGaD
